Versatile leader in clinical development operations, building the bridges for wellbeing, between biotech, health tech, clinical researchers, clinicians and patients
Flashback to the EXPO: Startup Creasphere Meets The Swiss Innovation Ecosystem, where Volv Global SA was present as one of the flagship innovative companies in Switzerland. Based at the Biopôle Lausanne, we focus on finding those patients that clinicians find difficult to recognise and typically remain undiagnosed. We arrived at this innovation, starting out from a real medical and (pharma) business problem statement that is common, not only in the rare disease space, but in many other more common indications: for many diseases, patients experience long diagnostic delays. One of our first customers had a drug in market for a disease with a prevalence of 4 per million, but only ever found 1. So, this is the basic problem we solve for. But we have now further refined our capabilities to find such patients significantly, demonstrably sooner than they might normally be diagnosed in clinical practice. And this is particularly important when dealing with progressive diseases. Also, we have developed methods to predict which patients are likely to progress quicker than others, so we can help direct focus, attention and often limited healthcare resources, to those that may need them most urgently. Want to learn more about what we do? How this helps HCPs improve patient care and optimise clinical workflows? The ways we help drug development companies accelerate their development programs? And support the commercial lifecycle of drugs in market for difficult to diagnose diseases? Contact us today! #inTrigue #inVolv #raredisease #diagnosis #aiinhealthcare #aiinnovation Biopôle Lausanne STARTUP CREASPHERE powered by Plug and Play Switzerland Innovation Park Basel Area Basel Area Business & Innovation Innosuisse
